This is a preview of subscription content, log in via an institution to check access.
References
Kim SG. Evolution of the management of malignant ventricular tachyarrhythmias: The roles of drug therapy and implantable defibrillators. Am Heart J 1995;130:1144–1150.
Poole JE, Mathisen TL, Kudenchek PJ, McAnulty JA, Swerdlow CD, Bardy GH, Greene HL. Long-term outcome in patients who survive out-of-hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol 1990;16:657–665.
Wilber JD, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988;318:19–24.
Mason JW, for the Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with Holter Monitoring to predict antiarrhythmic drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993;329:445–451.
Mason JW, for the Electrophysiologic study versus Electrocardiographic monitoring Investigators. Comparison of seven antiarrhythmiic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452–458.
The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993;72:280–287.
Kim SG, Pathapati R, Fisher JD, Rameneni A, Nagabhairu R, Ferrick KJ, Roth JA, Ben-Zur U, Gross JN, Brodman R, Furman S. Comparison of long-term outcomes of patients treated with nonthoracotomy and thoracotomy implantable defibrillators. Am J Cardiol 1996;78 (in press).
Kim SG, Fogoros RN, Furman S, Connolly SJ, Kuck KH, Moss AJ, for the participants of the Policy Conference. Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9–10, 1993. PACE Pacing Clin Electrophysiol 1993;16:1–5.
Powell AC, Fuchs TF, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JF. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083–1092.
Choue CW, Kim SG, Ferrick KJ, Roth JA, Fisher JD. Survival rates of patients with malignant ventricular arrhythmia: comparison of medical therapy versus implantable difibrillator therapy. Am J Cardiol 1994;73:1075–1079.
Gottlieb CD, Slivka T, Langan MN, Horowitz LN. Do implantable defibrillators prolong survival compared to electrophysiology guided drug therapy? [Abstract]. Circulation 1992;86:I–655.
Newman D, Suave MJ, Herre J, Langberg JL, Lee MA, Titus C, Franklin J, Scheinman MM, Griffin JC. Survival after implnatationof the cardiioverter defibrillator. Am J Cardiol 1992;69:899–903.
Bocker D, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithart G. Comparison of d, I-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996;94:151–157.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, S.G. Long-Term Management of Patients with Ventricular Fibrillation. Card Electrophysiol Rev 1, 127–129 (1997). https://doi.org/10.1023/A:1009908712078
Issue Date:
DOI: https://doi.org/10.1023/A:1009908712078